BostonGene Stock
BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.
Sign up today and learn more about BostonGene Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About BostonGene Stock
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies
Funding History
| 2019-04-01 | $50.0M |
|---|---|
| 2022-04-01 | $150M |
Management
President & CEO
Andrew Feinberg
Press
morningstar - Aug, 24 2023
BostonGene, NEC and JIP Form Joint Venture in Japanbusinesswire - Feb, 7 2023
BostonGene Showcases Comprehensive Approach to Precision Medicine at Immuno-Oncology 360°genomeweb - Sep, 8 2022
BostonGene, Mass General Hospital Cancer Center Form Research Alliancenews - May, 11 2022
Meet The 35 Unicorns Who Joined The Board In Aprilnews - Apr, 8 2022
The Week’s 10 Biggest Funding Rounds: Remote Brings Home $300M, Grand Ole Opry Raises $293M For A Songbddy - Apr, 8 2022
A new unicorn joins the herd with Bostongene’s latest fundraising roundstartuparound - Apr, 7 2022
BostonGene Announces $150M Series B Fundingbioworld - Dec, 25 2021
Nec partners with Bostongene to bring tumor analysis tests to Japanbiospace - Dec, 21 2021
BostonGene and NEC Announce Global Partnershipbiospace - Nov, 3 2021
BostonGene Announces Publication in Cancer Researchnews - Aug, 5 2020
BostonGene Announces Scientific Collaboration with Leading Cancer Centerbusinesswire - Jan, 17 2020
BostonGene Announces Scientific Collaboration with the Vaccine and Immunotherapy Center at Massachusetts General Hospitalbusinesswire - Dec, 10 2019
BostonGene and Weill Cornell Medicine Reveal Resultsbusinesswire - Sep, 17 2019
BostonGene Announces Agreement with The University of Texas MD Anderson Cancer CenterEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
